María José Jiménez‐Santos

Beyondcell: targeting cancer therapeutic heterogeneity in single-cell RNA-seq data

Coral Fustero‐Torre, María José Jiménez‐Santos, Santiago García‐Martín et al. · Genome Medicine · 2021 · 108 citations · Full text

CALR-mutated cells are vulnerable to combined inhibition of the proteasome and the endoplasmic reticulum stress response

Jonas S. Jutzi, Anna E. Marneth, María José Jiménez‐Santos et al. · Leukemia · 2022 · 22 citations · Full text

Calr-mutated Cells, Signal Transduction, Protein Function +12

Whole-genome CRISPR screening identifies <i>N-</i>glycosylation as a genetic and therapeutic vulnerability in <i>CALR</i>-mutant MPNs

Jonas S. Jutzi, Anna E. Marneth, Michele Ciboddo et al. · Blood · 2022 · 21 citations · Full text

Genetics, Molecular Biology, Molecular Genetics +16

<scp>RANK</scp> is a poor prognosis marker and a therapeutic target in <scp>ER</scp> ‐negative postmenopausal breast cancer

Marina Ciscar, Eva M. Trinidad, Gema Pérez-Chacón et al. · EMBO Molecular Medicine · 2023 · 18 citations · Full text

Influence of mutation bias and hydrophobicity on the substitution rates and sequence entropies of protein evolution

María José Jiménez‐Santos, Miguel Arenas, Ugo Bastolla · PeerJ · 2018 · 17 citations · Full text